We’re thrilled to invite you to our webinar where we unveil the future of GMP nanoencapsulation with our game changing product portfolio!
In this exclusive session, we’ll be introducing our proprietary FR-JET technology for nanoencapsulation, and tell you more about our devices NANOlab®, NANOme® and NANOus®.
Join us on December 4th, 2023 at 4PM CET
REGISTER HERE: LINK
leon-nanodrugs GmbH is a Munich-based pharmatech company specializing in the development of devices for the encapsulation of genetic material and other pharmaceutical active substances into nanocarriers, such as lipid nanoparticles (LNPs). LEON builds its innovative solutions based on its proprietary FR-JET® Technology. Its portfolio of devices, NANOscreen® for simplified formulation screening, NANOlab® for process development, and NANOme® and NANOus® for GMP aseptic manufacturing, enable faster route to clinical batches and are suitable for both individualised scales and commercial production.
LEON’s platform is aimed at enabling pharma companies, small biotech, research institutes, as well as CDMOs, to take full advantage of the significant progress being made in advanced therapies.
For general information and enquiries please email info@leon-nanodrugs.com
